Enprostil

Enprostil
(IUPAC) ime
Metil 7-[(1S,2S,3S)- 3-hidroksi-2-[(S,E)-3-hidroksi-4-fenoksibut-1-enil]-5-oksociklopentil]hepta-4,5-dienoat
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 73121-56-9
ATC kod A02BB02
PubChem[1][2] 51744
UNII J4IP5Z9DAU DaY
KEGG[3] D01891 DaY
Hemijski podaci
Formula C23H28O6 
Mol. masa 400,46 g/mol
SMILES eMolekuli & PubHem
InChI
InChI=1S/C23H28O6/c1-28-23(27)12-8-3-2-7-11-19-20(22(26)15-21(19)25)14-13-17(24)16-29-18-9-5-4-6-10-18/h3-7,9-10,13-14,17,19-20,22,24,26H,8,11-12,15-16H2,1H3/t2?,17-,19+,20+,22+/m1/s1 DaY
Key: PTOJVMZPWPAXER-JRIPZDIHSA-N DaY
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Enprostil je sintetički prostaglandin koji je sličan sa dinoprostonom. Enprostil je veoma potentan inhibitor sekrecije želudačne HCl.[4]

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  4. Roszkowski, AP; Garay, GL; Baker, S; Schuler, M; Carter, H (1986). „Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester”. The Journal of Pharmacology and Experimental Therapeutics 239 (2): 382–9. PMID 3095537. 

Literatura

  • Toshina, K.; Hirata, I.; Maemura, K.; Sasaki, S.; Murano, M.; Nitta, M.; Yamauchi, H.; Nishikawa, T. i dr.. (2000). „Enprostil, a Prostaglandin-E2 Analogue, Inhibits Interleukin-8 Production of Human Colonic Epithelial Cell Lines”. Scandinavian Journal of Immunology 52 (6): 570–5. DOI:10.1046/j.1365-3083.2000.00815.x. PMID 11119262. 
  • Tari, Akira; Hamada, Masanori; Kamiyasu, Toshiki; Sumii, Koji; Haruma, Ken; Inoue, Masaki; Kishimoto, Shinya; Kajiyama, Goro i dr.. (1997). „Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients”. Digestive Diseases and Sciences 42 (8): 1741–6. DOI:10.1023/A:1018825902055. PMID 9286243. 
  • Ching, C. K.; Lam, S. K. (1995). „A comparison of two prostaglandin analogues (enprostil vs misoprostol) in the treatment of acute duodenal ulcer disease”. Journal of Gastroenterology 30 (5): 607–14. DOI:10.1007/BF02367786. PMID 8574332. 

Spoljašnje veze

Portal Medicina
Portal Hemija
  • p
  • r
  • u
PrekursorProstanoidi
Prekursor
H2
Aktivni
D/J
D2
E/F
E2 (Dinoproston): Enprostil  Sulproston

E1 (Alprostadil): Mizoprostol  Gemeprost

F (Dinoprost): Bimatoprost  Karboprost  Latanoprost  Tafluprost  Travoprost  Unoproston
I
I2 (Prostaciklin/Epoprostenol): Beraprost  Iloprost  Treprostinil
A2  B2
Leukotrieni (LT)
Prekursor
Inicijalni
A4  B4
C4  D4  E4
Neklasični
Lipoksini (A4, B4 Virodhamin
Po funkciji
bronhokonstrikcija (PGF, TXA2, LTC4, LTD4, LTE4)

vazokonstrikcija (PGF, TXA2, TXB2 vazodilatacija (PGE2, PGI2, LTC4, LTD4, LTE4)

trombociti: indukuje (TXA2) inhibira (PGD2, PGI2 leukociti: indukuje (TXA2, LTB4) inhibira (PGD2, PGE2)

Porođaj stimulacija: (PGE2 (Dinoproston), PGF (Dinoprost))

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Biohemijske familije: Ugljeni hidrati (Glikozidi,Alkoholi) • Lipidi (Steroidi,Fosfolipidi,Glikolipidi,Masne kiseline,Tetrapiroli) • Proteini (Aminokiseline,Peptidi,Glikoproteini) • Nukleobaze/Nukleinske kiseline